SCHEMBL5776256

SCHEMBL5776256

CNCc1ccc(C=NNc2ccc(-c3cnco3)cc2)cc1[Sn](C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.35
LMNA P02545 3/20 0.35
IMPDH2 P12268 2/20 0.34
IMPDH1 P20839 1/20 0.34
AAK1 Q2M2I8 1/20 0.34
KMT2A Q03164 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
MEN1 O00255 1/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33
NPC1 O15118 5/20 0.33
RAB9A P51151 4/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5776252 1.00 PKM (0.35) PKMLMNAIMPDH2IMPDH1AAK1
SCHEMBL5778855 0.87 NPC1 (0.39) PKMLMNAIMPDH2IMPDH1AAK1
SCHEMBL5778848 0.87 NPC1 (0.39) PKMLMNAIMPDH2IMPDH1AAK1
SCHEMBL5780355 0.87 KMT2A (0.41) PKMLMNAIMPDH2IMPDH1AAK1
SCHEMBL5775283 0.87 LMNA (0.36) PKMLMNAIMPDH2IMPDH1AAK1
SCHEMBL5775279 0.87 LMNA (0.36) PKMLMNAIMPDH2IMPDH1AAK1
SCHEMBL5780353 0.87 KMT2A (0.41) PKMLMNAIMPDH2IMPDH1AAK1
SCHEMBL5779019 0.85 LMNA (0.36) PKMLMNAIMPDH2IMPDH1AAK1
SCHEMBL5779017 0.85 LMNA (0.36) PKMLMNAIMPDH2IMPDH1AAK1
SCHEMBL5779773 0.82 LMNA (0.40) PKMLMNAIMPDH2IMPDH1AAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276433-A1 Hydrazone derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-12-07 US disclosed
EP-1612204-A1 HYDRAZONE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276433-A1 Hydrazone derivative APP, PRNP, HTT PKM 3411/4885LMNA 861/4885IMPDH2 4694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.